Trials to Verify and Describe Clinical Benefit of Midodrine Hydrochloride; Establishment of Public Docket

Özet

The Food and Drug Administration (FDA) is announcing the opening of a public docket to provide a forum to facilitate communication regarding the conduct of clinical trials needed to verify and describe the clinical benefit of midodrine hydrochloride (HCl) when used to treat symptomatic orthostatic hypotension.